CTOs on the Move

ImmPACT Bio USA

www.immpact-bio.com

 
ImmPACT-Bio is pioneering a novel strategy to surmount a major challenge compromising current Chimeric Antigen Receptor T-cell (CAR-T) therapy. Our technology addresses the need to differentiate cancerous from non-cancerous tissues impacting the safety of the treatment which is to date a major limitation in reaching effectiveness.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details
Sylvain Roy
 Chief Technology Officer Profile

Funding

ImmPACT Bio USA raised $18M on 08/18/2020

Similar Companies

Encodia

Encodia is developing an innovative Next-Gen digital proteomics platform to enable democratized protein sequencing. Our goal is to make protein sequencing easy and ubiquitous by using a novel reverse-translation technology that turns peptide sequences into DNA. The DNA can be read by an NGS DNA sequencer, providing a path to breakthrough proteomics research at a scale that is not practical or cost-effective using current technologies.

Biolog

Biolog is a Hayward, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Synecor

Synecor is a Chapel Hill, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Xenotech

Xenotech is a Lenexa, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cancog Technologies

Cancog Technologies is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.